Mehmet Ci̇ngi̇rt
Research Subjects
Mehmet Ci̇ngi̇rt has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Yalcinkaya
Department of Medical Biochemistry, Faculty of Medicine, Hacettepe University, Ankara, Turkey
1 shared publication - Aydın Dalgıç
Faculty of Medicine, Department of General Surgery, Gazi University, Ankara, Turkey
1 shared publication - Aydın Yavuz
Department of General Surgery, Gazi University Faculty of Medicine, Ankara, Turkey
1 shared publication - Bayram Şen
Recep Tayyip Erdoğan University, Faculty of Medicine, Department of Biochemistry, Rize, Türkiye
1 shared publication - Esra Yılmaz
Clinical Biochemistry Laboratory, Karabük Training and Research Hospital, Karabuk 78200, Türkiye
1 shared publication - Hasan Bostancı
Department of General Surgery, Gazi University Faculty of Medicine, Ankara, Türkiye
1 shared publication
Latest Publications
- Open Access
- 21 April 2025
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
- Vol. 9 (1) , 68-73
Investigation of the Agreement between Glucose Meters Used for Glucose Measurement and Central Laboratory Measurements
Purpose: Blood glucose measurement is of great importance in preventing complications and reducing mortality and morbidity for several diseases. Glucometers are used by any healthcare professionals. We conducted this study to show the compatibility between glucometers and autoanalyzers as a basis for hospital procurement. Materials and Methods: Fourty seven venous samples were used. Correlation, Passing Bablok regression analysis, and Bland-Altman difference plot were used to evaluate the results (glucometers and autoanalyzer). Clarke Error Grid analysis was used to assess the clinical agreement (p<0.05). Results: The correlation coefficient for G1 was 0.9294 (p<0.001; 95% CI: 0.8761-0.9603) and 0.9473 (p<0.001; 95% CI: 0.9069-0.9705) for G2. Regression equations were G1 y=1.1235x+3.4662 G2 y=0.8846x+10.0076. In Clarke Error Grid analysis, the criterion of 99% of the data being in zone A or B was met for both glucometers. Conclusion: According to the relevant document, based on the result obtained with the reference method as the target value, 95% of all results less than 100 mg/dl should be within ±12 mg/dl of the target value. 95% of all results above 100 mg/dl should be within ±12.5% of the target value. In addition, the ratio of the sum of results less than 75 mg/dl exceeding ±15 mg/dl and results greater than 75 mg/dl exceeding ±20% of the target value to all results should be less than 2%. Glucometers didn’t fully meet the performance targets. We think that glucometer analysis results should be closely monitored and verified after procurement.
- 21 April 2025
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
- Vol. 9 (1) , 68-73
Open AccessInvestigation of the Agreement between Glucose Meters Used for Glucose Measurement and Central Laboratory Measurements
Purpose: Blood glucose measurement is of great importance in preventing complications and reducing mortality and morbidity for several diseases. Glucometers are used by any healthcare professionals. We conducted this study to show the compatibility between glucometers and autoanalyzers as a basis for hospital procurement. Materials and Methods: Fourty seven venous samples were used. Correlation, Passing Bablok regression analysis, and Bland-Altman difference plot were used to evaluate the results (glucometers and autoanalyzer). Clarke Error Grid analysis was used to assess the clinical agreement (p<0.05). Results: The correlation coefficient for G1 was 0.9294 (p<0.001; 95% CI: 0.8761-0.9603) and 0.9473 (p<0.001; 95% CI: 0.9069-0.9705) for G2. Regression equations were G1 y=1.1235x+3.4662 G2 y=0.8846x+10.0076. In Clarke Error Grid analysis, the criterion of 99% of the data being in zone A or B was met for both glucometers. Conclusion: According to the relevant document, based on the result obtained with the reference method as the target value, 95% of all results less than 100 mg/dl should be within ±12 mg/dl of the target value. 95% of all results above 100 mg/dl should be within ±12.5% of the target value. In addition, the ratio of the sum of results less than 75 mg/dl exceeding ±15 mg/dl and results greater than 75 mg/dl exceeding ±20% of the target value to all results should be less than 2%. Glucometers didn’t fully meet the performance targets. We think that glucometer analysis results should be closely monitored and verified after procurement.
- 30 September 2022
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 3 (3) , 181-186
The effect of silymarin given before partial hepatectomy on liver regeneration in rats with ischemic preconditioning during liver resection
Background: The regeneration capacity of liver tissue after partial hepatectomy closely affects morbidity and mortality. We aimed to investigate the effect of silymarin and ischemic preconditioning (IPC) before partial hepatectomy on liver regeneration. Methods: Thirty rats were randomly divided into 5 groups (n=6). Serum AST, bilirubin, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) values were studied 48 hours after hepatectomies. Mitotic count, congestion, necrosis, cytoplasmic vacuolization, and presence of neutrophils were evaluated histopathologically. Proliferating cell nuclear antigen (PCNA) antibody was studied immunohistochemically. Results: The AST value (2071.5±938.4) was the highest in the partial hepatectomy (PH) group. The Ischemic Preconditioning Partial Hepatectomy Group (IPC) (1535.5±204.8) and the Silymarin+Partial Hepatectomy Group (Silymarin group) (1192.3±526.3) had lower levels of AST values; however, the AST values were the lowest in the Silymarin+Ischemic Preconditioning+ Partial Hepatectomy Group (IPC+ Silymarin group) (1002.8±348.9). Likewise, the highest improvement in bilirubin levels was observed in the IPC+ Silymarin group (0.33±0.11). IL-6 (11.54±2.89) and TNF-α (39.2±22.73) values were the lowest in the IPC group, and interestingly, both were higher in the silymarin-treated groups. It was observed that these values increased in Silymarin group and IPC+ Silymarin group who received silymarin treatment compared to PH group and IPC group who did not receive silymarin. In histopathological analysis, it was found that the mitosis rate and PCNA percentage were higher in the Silymarin and IPC+ Silymarin groups. Conclusions: The use of silymarin before hepatectomy and IPC during partial hepatectomy increase liver regeneration.
- 30 September 2022
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 3 (3) , 181-186
The effect of silymarin given before partial hepatectomy on liver regeneration in rats with ischemic preconditioning during liver resection
Background: The regeneration capacity of liver tissue after partial hepatectomy closely affects morbidity and mortality. We aimed to investigate the effect of silymarin and ischemic preconditioning (IPC) before partial hepatectomy on liver regeneration. Methods: Thirty rats were randomly divided into 5 groups (n=6). Serum AST, bilirubin, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) values were studied 48 hours after hepatectomies. Mitotic count, congestion, necrosis, cytoplasmic vacuolization, and presence of neutrophils were evaluated histopathologically. Proliferating cell nuclear antigen (PCNA) antibody was studied immunohistochemically. Results: The AST value (2071.5±938.4) was the highest in the partial hepatectomy (PH) group. The Ischemic Preconditioning Partial Hepatectomy Group (IPC) (1535.5±204.8) and the Silymarin+Partial Hepatectomy Group (Silymarin group) (1192.3±526.3) had lower levels of AST values; however, the AST values were the lowest in the Silymarin+Ischemic Preconditioning+ Partial Hepatectomy Group (IPC+ Silymarin group) (1002.8±348.9). Likewise, the highest improvement in bilirubin levels was observed in the IPC+ Silymarin group (0.33±0.11). IL-6 (11.54±2.89) and TNF-α (39.2±22.73) values were the lowest in the IPC group, and interestingly, both were higher in the silymarin-treated groups. It was observed that these values increased in Silymarin group and IPC+ Silymarin group who received silymarin treatment compared to PH group and IPC group who did not receive silymarin. In histopathological analysis, it was found that the mitosis rate and PCNA percentage were higher in the Silymarin and IPC+ Silymarin groups. Conclusions: The use of silymarin before hepatectomy and IPC during partial hepatectomy increase liver regeneration.